Dyslipidemia and PCSK9 inhibitors - practical focused update of indication and reimbursement criteria
{{output}}
PCSK9 inhibitors are modern and effective hypolipidemic drugs for lowering LDL-cholesterol, which belong to the „biological therapy“. Their prescription is limited to specialized centers and to the fulfillment of other conditions set by SÚKL. This... ...
